Skip to content
Dr Tom Payne

Dr Tom Payne

Chief Scientific Officer

Tom has more than 15 years commercial experience in biopharmaceutical development and bioproduction. He has previously held R&D and commercially-focused roles at both Novozymes Biopharma (now Albumedix) and Lonza in the UK.

At OXGENE, Tom is responsible for technology development activities, spanning the breadth of services and products offered. His research interests include gene editing, synthetic biology and cellular engineering. Tom holds a BSc and Ph.D in Molecular Biology from the University of Nottingham.

We use cookies to give you the best experience of using this website. By continuing to use this site, you accept our use of cookies. Please read our Cookie Policy for more information.

Our single technology platform that fully connects our smart labs with our customer service proposition.


Connex revolutionises DNA design, optimization and assembly by ensuring the highest levels of qualify control, efficiency and project management available for any client.

OXGENE has fully integrated all its smart labs, machine learning and robotic production processes within a single technology platform that allows real-time project updates for our customers.